Overview
Dr. Wei Bai grew up in Beijing, China. In 1995, she graduated from Peking University Health Science Center (previously known as Beijing Medical University) with distinction. She then pursued graduate study in the United States. Upon receiving her master’s degree in Molecular Medicine from the University of Massachusetts Medical School in 1998, Dr. Bai joined a leading biotech company, Genentech, Inc., in South San Francisco to pursue her passion in translational research. She participated in research and development of several cancer drugs, including trastuzumab (Herceptin), bevacizumab (Avastin), and erlotinib (Tarceva), among others in the company pipeline.Excited to bring bench research to bedside practice, Dr. Bai ultimately transitioned to direct patient care in 2005. She completed her Internal Medicine residency at NewYork-Presbyterian Lower Manhattan Hospital in 2008, which included several months of clinical rotation at Memorial loan Kettering Cancer Center (MSKCC). Dr. Bai’s experience at MSKCC further enforced her commitment to oncology research and practice. She proceeded to a combined Hematology and Medical Oncology fellowship at Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC from 2008 to 2011.After her fellowship, Dr. Bai practiced hematology and medical oncology in the Samaritan Health System in Oregon. During her nine years with Samaritan, she treated patients with a wide range of cancer types and blood diseases. She served her patients with PRIDE — passion, respect, integrity, dedication and excellence. Dr. Bai was also active in clinical trials and resident education.Since 2020, Dr. Bai joined the team at Mission Hope Cancer Center. Compassionate and calm, she is devoted to each individual patient’s needs and goals.
Dr. Bai is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Deep Vein Thrombosis, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Hemochromatosis.
Her clinical research consists of co-authoring 14 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1325 E Church St, Ste 301, Santa Maria, CA 93454
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Stanford Health Care
Gregory Heestand is an Oncologist and a Hematologist Oncology provider in Templeton, California. Dr. Heestand is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Tissue Biopsy.
UCLA Health Hematology Oncology
Brian Dicarlo is an Oncologist in San Luis Obispo, California. Dr. Dicarlo is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Familial Pancreatic Cancer, Paget Disease of the Breast, Lung Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Dicarlo is currently accepting new patients.
Pcr Oncology Inc
Erick Hjortsvang is a Hematologist and an Oncologist in Arroyo Grande, California. Dr. Hjortsvang is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Essential Thrombocythemia, Chronic Lymphocytic Leukemia (CLL), Familial Colorectal Cancer, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Deep Vein ThrombosisDr. Bai isDistinguished. Learn about Deep Vein Thrombosis.
- Familial Colorectal CancerDr. Bai isDistinguished. Learn about Familial Colorectal Cancer.
- Pleuropulmonary BlastomaDr. Bai isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- AnemiaDr. Bai isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Bai isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Bai isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- Colorectal CancerDr. Bai isAdvanced. Learn about Colorectal Cancer.
- Essential ThrombocythemiaDr. Bai isAdvanced. Learn about Essential Thrombocythemia.
- Experienced
- Acute Mountain SicknessDr. Bai isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Bai isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adrenal CancerDr. Bai isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Bai isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Bai isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Bai isExperienced. Learn about Agranulocytosis.